MFHAS1, regulated by TF MYCN in our remission sub-network, may be a significant prognosis factor for AML in The Cancer Genome Atlas (TCGA) cohort (Figure 3B) and could promote the progress of cancer.36 This evidence concerns the gene MYCN and cancer.